EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration

Chiara Mancino, Anna Pasto, Enrica De Rosa, Luigi Dolcetti, Marco Rasponi, Patrick McCulloch, Francesca Taraballi

Heliyon · 2023-06 · 9 (6) · e16640

DOI: 10.1016/j.heliyon.2023.e16640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heliyon, 2023-06. Verfasst von Chiara Mancino und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, TX, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-traumatic osteoarthritis (PTOA) is one of the leading causes of disability in developed countries and accounts for 12% of all osteoarthritis cases in the United States. After trauma, inflammatory cells (macrophages amongst others) are quickly recruited within the inflamed synovium and infiltrate the joint space, initiating dysregulation of cartilage tissue homeostasis. Current therapeutic strategies are ineffective, and PTOA remains an open clinical challenge. Here, the targeting potential of liposome-based nanoparticles (NPs) is evaluated in a PTOA mouse model, during the acute phase of inflammation, in both sexes. NPs are composed of biomimetic phospholipids or functionalized with macrophage membrane proteins. Intravenous administration of NPs in the acute phase of PTOA and advanced in vivo imaging techniques reveal preferential accumulation of NPs within the injured joint for up to 7 days post injury, in comparison to controls. Finally, imaging mass cytometry uncovers an extraordinary immunomodulatory effect of NPs that are capable of decreasing the amount of immune cells infiltrating the joint and conditioning their phenotype. Thus, biomimetic NPs could be a powerful theranostic tool for PTOA as their accumulation in injury sites allows their identification and they have an intrinsic immunomodulatory effect.

Schlagwörter

Stichwörter der Autor:innen

Biomimetic nanoparticlesImmunomodulationPosttraumatic osteoarthritisTheranostics

Autor:innen und Institutionen

  • Center for Musculoskeletal Regeneration, Houston Methodist Academic Institute, Houston, TX, USA.
  • Orthopedics and Sports Medicine, Houston Methodist Hospital, Houston, TX, USA.
  • Department of Electronics, Information and Bioengineering, Politecnico di Milano, Milano, Italy.
  • Richard Dimbleby Laboratory of Cancer Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.

Zitieren

APA

Mancino, C., Pasto, A., De Rosa, E., Dolcetti, L., Rasponi, M., McCulloch, P., & Taraballi, F. (2023). Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration. Heliyon, 9(6), e16640. https://doi.org/10.1016/j.heliyon.2023.e16640

Vancouver

Mancino C, Pasto A, De Rosa E, Dolcetti L, Rasponi M, McCulloch P, et al. Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration. Heliyon. 2023;9(6):e16640. doi:10.1016/j.heliyon.2023.e16640

BibTeX
@article{Mancino2023,
  author = {Mancino, Chiara and Pasto, Anna and De Rosa, Enrica and Dolcetti, Luigi and Rasponi, Marco and McCulloch, Patrick and Taraballi, Francesca},
  title = {Immunomodulatory biomimetic nanoparticles target articular cartilage trauma after systemic administration},
  journal = {Heliyon},
  year = {2023},
  volume = {9},
  number = {6},
  pages = {e16640},
  doi = {10.1016/j.heliyon.2023.e16640}
}
Kostenlos starten →